MLICM
WVE icon

Metropolitan Life Insurance Company (MetLife)’s Wave Life Sciences WVE Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-3,918
Closed -$24.2K – 2129
2024
Q1 		$24.2K Buy
3,918
+662
+20% +$3.31K ﹤0.01% 1764
2023
Q4 		$16.4K Hold
3,256
– – ﹤0.01% 1999
2023
Q3 		$18.7K Hold
3,256
– – ﹤0.01% 1931
2023
Q2 		$11.9K Buy
+3,256
New +$13.2K ﹤0.01% 2212
2021
Q1 		– Sell
-11,094
Closed -$87.3K – 2601
2020
Q4 		$87.3K Buy
11,094
+3,388
+44% +$28.4K ﹤0.01% 2407
2020
Q3 		$65.4K Buy
7,706
+261
+4% +$2.86K ﹤0.01% 2427
2020
Q2 		$77.5K Hold
7,445
– – ﹤0.01% 2395
2020
Q1 		$69.8K Buy
7,445
+499
+7% +$4.25K ﹤0.01% 2252
2019
Q4 		$55.7K Sell
6,946
-909
-12% -$22.3K ﹤0.01% 2490
2019
Q3 		$161K Buy
7,855
+1,802
+30% +$41.3K ﹤0.01% 2020
2019
Q2 		$158K Hold
6,053
– – ﹤0.01% 2041
2019
Q1 		$235K Buy
+6,053
New +$246K ﹤0.01% 1791

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MCM
M28 Capital Management Stamford, Connecticut $53.8M AUM 28.63% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s WVE Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Wave Life Sciences (WVE) in Q2 2024, closing a stake of 3,918 shares — an estimated $24.2K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in WVE in Q1 2019 and held it in 12 quarters. The position peaked at $235K in Q1 2019. 144 funds tracked by Wall St. Rank hold WVE as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Wave Life Sciences position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 3,918 Wave Life Sciences shares in Q2 2024, an estimated $24.2K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Wave Life Sciences in Q1 2019 and held it in 12 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Wave Life Sciences position peaked at $235K in Q1 2019.
  • 144 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.